SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Cost-effectiveness of Functional Imaging Tests in the Diagnosis of Alzheimer Disease
10 references·3 citing·43 second hop
Cost-effectiveness of Functional Imaging Tests in the Diagnosis of Alzheimer Disease (2000)Cost-effectiveness of Functional Imaging …Bureau of Labor Statistics Web Site (2000)Bureau of Labor Statistics We…Utility Scores for Chronic Conditions in a Community-Dwelling Population (1999)Utility Scores for Chronic Co…Health Utilities in Alzheimer's Disease (1999)Health Utilities in Alzheimer…Economic Evaluation of Donepezil for the Treatment of Alzheimer's Disease in Canada (1999)Economic Evaluation of Donepe…Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer’s disease (1999)Cost-effectiveness of donepez…EVALUATING THE COST-EFFECTIVENESS OF CLINICAL AND PUBLIC HEALTH MEASURES (1998)EVALUATING THE COST-EFFECTIVE…Clinical and Polysomnographic Features of Sleep-Related Eating Disorder (1998)Clinical and Polysomnographic…Economic foundations of cost-effectiveness analysis (1997)Economic foundations of cost-…Cost-Effectiveness in Health and Medicine (1996)Cost-Effectiveness in Health …The Beaver Dam Health Outcomes study (1993)The Beaver Dam Health Outcome…Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer’s Disease Interventions (2019)Family and Caregiver Spillove…Model-Based Economic Evaluation in Alzheimer's Disease: A Review of the Methods Available to Model Alzheimer's Disease Progression (2011)Model-Based Economic Evaluati…Health State Values for Use in the Economic Evaluation of Treatments for Alzheimerʼs Disease (2011)Health State Values for Use i…Clinical Decision Analysis (1980)Markov Models in Medical Decision Making (1993)Usefulness of US Cost-of-Illness Studies in Healthcare Decision Making (2001)An Economic Evaluation of Donepezil in Mild to Moderate Alzheimer’s Disease: Results of a 1-Year, Double-Blind, Randomized Trial (2002)Methods for the Economic Evaluation of Health Care Programmes (2005)Methodological considerations in cost of illness studies on Alzheimer disease (2012)Methods for the economic evaluation of health care programmes (1987)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)The MOS 36-ltem Short-Form Health Survey (SF-36) (1992)One Thousand Health-Related Quality-of-Life Estimates (2000)Swedish population health-related quality of life results using the EQ-5D (2001)Preference-Based EQ-5D Index Scores for Chronic Conditions in the United States (2006)Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)BAYESIAN VALUE-OF-INFORMATION ANALYSIS (2001)When should decision-analytic modeling be used in the economic evaluation of health care? (2003)Common Methodological Flaws in Economic Evaluations (2005)EuroQol - a new facility for the measurement of health-related quality of life (1990)EQ-5D in Patients With Dementia An Investigation of Inter-Rater Agreement (2001)The Association Between Caregiver Burden and Caregiver Health-Related Quality of Life in Alzheimer Disease (2001)Utility-based Quality of Life Measures in Alzheimer’s Disease (2006)The utility of different health states as perceived by the general public (1978)Measurement of health state utilities for economic appraisal (1986)Health Utilities Index Mark 3 (2000)The Utility of Health States After Stroke (2001)The Impact of Chronic Hepatitis B on Quality of Life: A Multinational Study of Utilities from Infected and Uninfected Persons (2008)Foundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)Uncertainty (1990)Cost and quality under managed care: irreconcilable differences? (2000)Variation in the Estimation of Quality-adjusted Life-years by Different Preference-based Instruments (2003)Lessons from Cost-Effectiveness Research for United States Public Health Policy (2007)Risk Aversion in the Small and in the Large (1964)Decision Making in Health and Medicine: Integrating Evidence and Values (2001)The Value of a Statistical Life: A Critical Review of Market Estimates Throughout the World (2002)Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold (2008)EQ-SD: a measure of health status from the EuroQol Group (2001)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Nocturnal Eating: Sleep-Related Eating Disorder or Night Eating Syndrome? A Videopolysomnographic Study (2006)A review of nighttime eating disorders (2008)Parasomnias: An Updated Review (2012)Agent-based modeling of climate policy: An introduction to the ENGAGE multi-level model framework (2012)Forecasting Engineering News-Record Construction Cost Index Using Multivariate Time Series Models (2013)Economic Recession, Alcohol, and Suicide Rates: Comparative Effects of Poverty, Foreclosure, and Job Loss (2016)
this work references cited by second hop

References

  • 1996Cost-Effectiveness in Health and Medicine7,192 cited
  • 1997Economic foundations of cost-effectiveness analysis767 cited
  • 1993The Beaver Dam Health Outcomes study734 cited
  • 1999Utility Scores for Chronic Conditions in a Community-Dwelling Population252 cited
  • 1999Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer’s disease244 cited
  • 2000Bureau of Labor Statistics Web Site181 cited
  • 1999Health Utilities in Alzheimer's Disease176 cited
  • 1998Clinical and Polysomnographic Features of Sleep-Related Eating Disorder165 cited
  • 1998EVALUATING THE COST-EFFECTIVENESS OF CLINICAL AND PUBLIC HEALTH MEASURES147 cited
  • 1999Economic Evaluation of Donepezil for the Treatment of Alzheimer's Disease in Canada125 cited

Cited by

  • 2011Model-Based Economic Evaluation in Alzheimer's Disease: A Review of the Methods Available to Model Alzheimer's Disease Progression73 cited
  • 2019Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer’s Disease Interventions69 cited
  • 2011Health State Values for Use in the Economic Evaluation of Treatments for Alzheimerʼs Disease64 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work